DK0950062T3 - Proteinmarkörer for esophageal cancer - Google Patents

Proteinmarkörer for esophageal cancer

Info

Publication number
DK0950062T3
DK0950062T3 DK97927689T DK97927689T DK0950062T3 DK 0950062 T3 DK0950062 T3 DK 0950062T3 DK 97927689 T DK97927689 T DK 97927689T DK 97927689 T DK97927689 T DK 97927689T DK 0950062 T3 DK0950062 T3 DK 0950062T3
Authority
DK
Denmark
Prior art keywords
esophageal cancer
protein markers
proteins
tissue
ipg
Prior art date
Application number
DK97927689T
Other languages
English (en)
Inventor
Samir Hanash
David G Beer
Rork Kuick
Robert Hinderer
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan filed Critical Univ Michigan
Application granted granted Critical
Publication of DK0950062T3 publication Critical patent/DK0950062T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK97927689T 1996-05-30 1997-05-29 Proteinmarkörer for esophageal cancer DK0950062T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1865996P 1996-05-30 1996-05-30

Publications (1)

Publication Number Publication Date
DK0950062T3 true DK0950062T3 (da) 2006-08-14

Family

ID=21789115

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97927689T DK0950062T3 (da) 1996-05-30 1997-05-29 Proteinmarkörer for esophageal cancer

Country Status (10)

Country Link
EP (1) EP0950062B1 (da)
JP (1) JP4993799B2 (da)
AT (1) ATE323103T1 (da)
AU (1) AU739306B2 (da)
CA (1) CA2264963C (da)
DE (1) DE69735676T2 (da)
DK (1) DK0950062T3 (da)
ES (1) ES2258278T3 (da)
NZ (1) NZ333075A (da)
WO (1) WO1997045445A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002951153A0 (en) * 2002-09-02 2002-09-19 Proteome Systems Intellectual Property Pty Ltd An electrophoresis gel having improved swelling properties
EP1739173A1 (en) * 2004-03-29 2007-01-03 Medical & Biological Laboratories Co., Ltd. Kit for solid cancer diagnosis and medicine for solid cancer therapy
US8222393B2 (en) 2004-06-02 2012-07-17 Tss Biotech Inc. Polypeptide useful for cancer diagnosis and treatment
GB0521521D0 (en) * 2005-10-21 2005-11-30 Medical Res Council Diagnostic methods and kits
US8945849B2 (en) 2008-05-21 2015-02-03 Toray Industries, Inc. Method for diagnosing esophageal cancer

Also Published As

Publication number Publication date
DE69735676D1 (de) 2006-05-24
ES2258278T3 (es) 2006-08-16
WO1997045445A1 (en) 1997-12-04
EP0950062A4 (en) 2000-07-05
EP0950062B1 (en) 2006-04-12
CA2264963A1 (en) 1997-12-04
DE69735676T2 (de) 2006-10-19
ATE323103T1 (de) 2006-04-15
AU3208997A (en) 1998-01-05
JP2000511536A (ja) 2000-09-05
AU739306B2 (en) 2001-10-11
NZ333075A (en) 2000-05-26
CA2264963C (en) 2010-03-09
JP4993799B2 (ja) 2012-08-08
EP0950062A1 (en) 1999-10-20

Similar Documents

Publication Publication Date Title
DK0961780T3 (da) Proteinmarkörer for lungecancer og anvendelse deraf
WO1998035985B1 (en) Protein markers for lung cancer and use thereof
TR199902818T2 (xx) Be�eri kullan�m i�in antikorlar ve be�eri kullan�m i�in antikorlar olu�turmak i�in y�ntemler.
WO2004000094A8 (en) Predictive markers in cancer therapy
NO2007014I2 (no) Anti-VEGF-antistoff, sammensetning, nukleinsyre, vektor, vertcelle, fremgangsmåte samt medikament for medisinsk bruk
ATE347360T1 (de) Verfahren zur induktion von krebszellentod und tumorregression
DE69428764D1 (de) Immunokonjugate
PL366575A1 (pl) Kompozycje oraz sposoby leczenia i diagnozowania raka jajnika
DE69833014D1 (de) Menschliche toll homologen
EP1274861A4 (en) COMPOSITIONS AND METHODS FOR IDENTIFICATION AND TARGETING OF CANCER CELLS
ES2141249T3 (es) Procedimiento para la identificacion de celulas humanas y animales que presentan la capacidad para una proliferacion ilimitada o para una formacion de tumores.
EP0772625A4 (en) Oligonucleoside compounds and methods for inhibiting tumor growth, invasion and metastasis
DE60044350D1 (de) Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs
DE69735676D1 (de) Proteinmarker für ösophaguskrebs
DK0833948T3 (da) Tyktarmspecifikt gen og protein
DE69636041D1 (de) Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen
AU5298696A (en) Tumor marker protein for cancer risk assessment
BR0012301A (pt) Inibidores de crescimento de células epiteliais
DE59712604D1 (de) Mittel zur identifizierung und therapie metastasierender tumore
WO2001059114A3 (en) Tumor suppressor gene, p47ing3
WO2003054008A3 (en) Mammalian simp protein, gene sequence and uses thereof in cancer therapy